In the MediaHome› Company Overview› News & Events› In the MediaNovember 29, 2021 iCAD announces data on ProFound AI at RSNA 2021 Read MoreOctober 28, 2021 Innovation in Breast Cancer Screening Read MoreOctober 27, 2021 Why Breast Cancer Risk Assessment is Key to Improving Outcomes Read MoreOctober 27, 2021 AI in breast cancer diagnostics: why we need standardized classification of breast density and quality in mammography Read MoreOctober 13, 2021 Sen. Hassan visits Nashua-based medical technology firm iCAD for unveiling of world’s first commercially available breast-cancer detection software Read MoreJuly 21, 2021 The first Digital Tomosynthesis Mastographer with 2D & 3D Artificial Intelligence Software in G.N. Read MoreJune 18, 2021 Latest iCAD 3D mammography AI gains CE mark Read MoreJune 15, 2021 Latest Version of iCAD’s Breast Imaging Software Gets CE Mark Read MoreJune 14, 2021 Mammographic Microcalcifications and Risk of Breast Cancer Read MoreJune 11, 2021 iCAD and Sectra partner on distribution for ProFound AI Read MoreJune 8, 2021 iCAD (ICAD) Receives a Buy from Oppenheimer Read MoreMay 7, 2021 The effect on interval cancer rates of the use of an AI-based algorithm in mammography Read More Previous 1 … 7 8 9 10 11 … 23 Next
